Bills · HR 10369
IN COMMITTEE· 119TH CONGRESS
House BillHR 10369Health
Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026
INTRO SEP 14· LAST ACTION SEP 14
READING
22MIN
COSPONSORS
4BIPARTISAN
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
SPONSORSHIP
1 + 4
R· Pennsylvania
YRS IN OFFICE
1
BILLS LED
32
COSPONSOR BREAKDOWNBIPARTISAN · 100%
DEM 2 REP 2 IND 0
ACTION TIMELINE
2 EVENTSSEP 14
Introduced in House
SEP 14
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
BILL INFO
TypeHouse Bill
NumberHR 10369
Congress119th
StatusIn Committee
IntroducedSep 14, 2026
Last actionSep 14, 2026
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · WAYS AND MEANS COMMITTEE · INTRODUCED SEP 14, 2026
House BillHR 10369Health
Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026
INTRODUCED SEP 14, 2026· LAST ACTION SEP 14, 2026
PASSAGE CHANCES
—%
READING
22 min
COSPONSORS
4
COMPLEXITY
Moderate
